HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding HCW Biologics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 12 | −3 |
| SharesConverted for a 1-for-6 split | 75.0K | 103.5K | +28.5K (+38.1%) |
| Value | $160.8K | $515.7K | +$354.8K (+220.6%) |
New holders (3)
Institutions that held HCW Biologics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 3,338 | $16.7K | 0.01% |
| Barclays PLC | 191 | $953 | 0.00% |
| Caitong International Asset Management Co., Ltd | 11 | $10 | 0.00% |
Sold out (6)
Institutions that held HCW Biologics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Virtu Financial LLC | 47,809 | $17.0K |
| Geode Capital Management, LLC | 35,886 | $12.9K |
| Citigroup Inc | 10,528 | $3.79K |
| Wells Fargo & Company | 1,000 | $360 |
| Northwestern Mutual Wealth Management Co | 2 | $1 |
| SBI Securities Co., Ltd. | 1 | $0 |